FOXM1 and acute myeloid leukemia: In addition, and similarly to EGCG, curcumin inactivation of FoxM1 was found to impact its downstream genes including, MMP-9 and vascular endothelial growth factor, leading to the reduction in survival and angiogenesis, and enhanced chemosensitivity in AML [46].